Ardelyx (ARDX) Change in Inventory (2022 - 2026)
Ardelyx's (ARDX) quarterly Change in Inventory came in at $4.9 million in Q1 2026, down 66.53% YoY from $14.7 million in Q1 2025, and up 178.68% on a QoQ basis from -$6.3 million in Q4 2025.
Ardelyx (ARDX) Change in Inventory (2022 - 2026) Analysis & Trends
Ardelyx (ARDX) has 5 years of Change in Inventory data on file, last reported at $4.9 million in Q1 2026.
- Quarterly Change in Inventory fell 66.53% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.1 million (down 18.02% YoY) and the FY2025 annual result came in at $31.9 million, down 23.44% from the prior year.
- Change in Inventory advanced to $4.9 million in Q1 2026, from -$6.3 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $29.4 million in Q1 2024 to a low of -$6.3 million in Q4 2025.
- A 5-year average of $7.5 million and a median of $4.9 million in 2026 frame the typical range for Change in Inventory.
- Annual changes were most pronounced in 2024 — Change in Inventory surged 516.91% — and 2025, when it plunged 203.73%.
- Tracing ARDX's Change in Inventory over 5 years: stood at $18.6 million in 2022, then sank by 89.29% to $2.0 million in 2023, then surged by 202.97% to $6.0 million in 2024, then sank by 203.73% to -$6.3 million in 2025, then jumped by 178.68% to $4.9 million in 2026.
- The last three Change in Inventory figures came in at $4.9 million (Q1 2026), -$6.3 million (Q4 2025), and $6.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 27.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 28.20 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 47.15 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,188.52 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -280,000.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 12.97 Mn |
| 10 | Ardelyx | 1.01 Bn | 729.71 Mn | 115.12 Mn | 10.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.96 Mn |
| Jun 30, 2026 | 10.96 Mn |
| Mar 31, 2026 | 4.92 Mn |
| Mar 31, 2026 | 4.92 Mn |
| Dec 31, 2025 | -6.25 Mn |
| Dec 31, 2025 | -6.25 Mn |
| Sep 30, 2025 | 6.10 Mn |
| Sep 30, 2025 | 6.10 Mn |
| Jun 30, 2025 | 17.38 Mn |
| Jun 30, 2025 | 17.38 Mn |
| Mar 31, 2025 | 14.69 Mn |
| Mar 31, 2025 | 14.69 Mn |
| Dec 31, 2024 | 6.03 Mn |
| Dec 31, 2024 | 6.03 Mn |
| Sep 30, 2024 | 1.73 Mn |
| Sep 30, 2024 | 1.73 Mn |
| Jun 30, 2024 | 4.57 Mn |
| Jun 30, 2024 | 4.57 Mn |
| Mar 31, 2024 | 29.37 Mn |
| Mar 31, 2024 | 29.37 Mn |